Role of MCP-1 in cardiovascular disease: Molecular mechanisms and clinical implications

Clinical Science

Volumn 117, Issue 3, 2009, Pages 95-109

  Niu, Jianli ^a   Kolattukudy, Pappachan E ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Atherosclerosis; Inflammation; Ischaemic cardiomyopathy; Monocyte chemotactic protein 1 (MCP 1)

Indexed keywords

ANTIBODY; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR2 ANTIBODY; CHEMOKINE RECEPTOR CXCR2; GLUCOSE REGULATED PROTEIN 78; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1 ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; PIOGLITAZONE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ANGIOGENESIS; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROTIC PLAQUE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DIABETES MELLITUS; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HUMAN; HYPERLIPIDEMIA; INFLAMMATORY INFILTRATE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; LEG ISCHEMIA; MYOCARDITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; REPERFUSION INJURY; RESTENOSIS; REVIEW; TISSUE REPAIR; TRANSCRIPTION REGULATION; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SMOOTH MUSCLE; ANIMAL; GRAFT REJECTION; METABOLISM; MONOCYTE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; CHEMOKINE CCL2; DIABETES MELLITUS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MONOCYTES; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; OBESITY; RECEPTORS, CCR2; STRESS, PHYSIOLOGICAL;

EID: 70149111743     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080581     Document Type: Review

References (120)

1. Taqueti, V. R., Mitchell, R. N. and Lichtman, A. H. (2005) Protecting the pump: controlling myocardial inflammatory response. Annu. Rev. Physiol. 68, 67-95
2. Knuefermann, P., Vallejo, J. and Mann, D. L. (2004) The role of innate immune responses in the heart in health and disease. Trends Cardiovasc. Med. 14, 1-7
3. Dawson, J., Miltz, W., Mir, A. K. and Wiessner, C. (2003) Targeting monocyte chemoattractant protein-1 signalling in disease. Expert Opin. Ther. Targets 7, 35-48
4. Gerszten, R. F., Mach, F., Sauty, A., Rosenzweig, A. and Luster, A. D. (2000) Chemokines, leukocytes, and atherosclerosis. J. Lab. Clin. Med. 136, 87-92
5. Aiello, R. J., Bourassa, P. A. K., Lindsey, S., Weng, W., Natoli, E., Rollins, B. J. and Milos, P. M. (1999) Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19, 1518-1525
6. Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P. and Rollins, B. J. (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2, 275-281
7. Zhong, L., Chen, W. Q., Ji, X. P., Zhang, M., Zhao, Y. X., Yao, G. H., Zhang, P. F., Zhang, C. and Zhang, Y. (2008) Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels. J. Cell. Mol. Med. 4, 2362-2371
8. Gosling, J., Slaymaker, S., Gu, L., Tseng, S., Zlot, C. H., Young, S. G., Rollins, B. J. and Charo, I. F. (1999) MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 103, 773-778
9. Zhu, Z., Ma, B., Zheng, T., Homer, R. J., Lee, C. G., Charo, I. F., Noble, P. and Elias, J. A. (2002) IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodelling. J. Immunol. 168, 2953-2962
10. - mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897
11. Han, K. H., Tangirala, R. K., Green, S. R. and Quehenberger, O. (1998) Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Arterioscler. Thromb. Vasc. Biol. 18, 1983-1991
12. Roque, M., Kim, W. J., Gazdoin, M., Malik, A., Reis, E. D., Fallon, J. T., Badimon, J. J., Charo, I. F. and Taubman, M. B. (2002) CCR2 deficiency decreases intimal hyperplasia after arterial injury. Arterioscler. Thromb. Vasc. Biol. 22, 554-559
13. Szalai, C., Duba, J., Prohászka, Z., Kalina, A., Szabó, T., Nagy, B., Horváth, L. and Császár, A. (2001) Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 158, 233-239
14. Ortlepp, J. R., Vesper, K., Mevissen, V., Schmitz, F., Albrecht, M., Maya-Pelzer, P., Hanrath, P., Weber, C., Zerres, K. and Hoffmann, R. (2003) Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age. J. Mol. Med. 81, 363-367
15. Bjarnadottir, K., Eiriksdottir, G., Aspelund, T. and Gudnason, V. (2006) Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population. Atherosclerosis 188, 341-346
16. Valdes, A. M., Wolfe, M. L., O'Brien, E. J., Spurr, N. K., Gefter, W., Rut, A., Groot, P. H. and Rader, D. J. (2002) Val64Ile polymorphism in the C-C chemokine receptor 2 is associated with reduced coronary artery calcification. Arterioscler. Thromb. Vasc. Biol. 22, 1924-1928
17. Yao, T.C., Kuo,M. L., See, L.C., Ou, L. S., Lee, W. I., Chan, C. K. and Huang, J. L. (2006) RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile rheumatoid arthritis: a six-year longitudinal study. Arthritis Rheum. 54, 2585-2593
18. Aukrust, P., Berge, R. K., Ueland, T., Aaser, E., Damås, J. K., Wikeby, L., Brunsvig, A., Müller, F., Forfang, K., Frøland, S. S. and Gullestad, L. (2001) Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. J. Am. Coll. Cardiol. 37, 485-491
19. Economou, E., Tousoulis, D., Katinioti, A., Stefanadis, C., Trikas, A., Pitsavos, C., Tentolouris, C., Toutouza, M. G. and Toutouzas, P. (2001) Chemokines in patients with ischemic heart disease and the effect of coronary angioplasty. Int. J. Cardiol. 80, 55-60
20. Deo, R., Khera, A., McGuire, D. K., Murphy, S. A., Meo Neto Jde, P.,Morrow,D.A., de Lemos, J. A. and Donald, W. (2004) Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J. Am. Coll. Cardiol. 44, 1812-1818
21. Tang, W., Pankow, J. S., Carr, J. J., Tracy, R. P., Bielinski, S. J., North, K. E., Hopkins, P. N., Kraja, A. T. and Arnett, D. K. (2007) Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study. BMC Cardiovasc. Disord. 7, 30-41
22. de Lemos, J. A., Morrow, D. A., Blazing, M. A., Jarolim, P., Wiviott, S. D., Sabatine, M. S., Califf, R. M. and Braunwald, E. (2007) Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. J. Am. Coll. Cardiol. 50, 2117-2124
23. Marfella, R., D'Amico, M., Di Filippo, C., Baldi, A., Siniscalchi, M., Sasso, F. C., Portoghese, M., Carbonara, O., Crescenzi, B., Sangiuolo, P. et al. (2006) Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque. J. Am. Coll. Cardiol. 47, 2444-2455
24. Mori, E., Komori, K., Yamaoka, T., Tanii, M., Kataoka, C., Takeshita, A., Usui, M., Egashira, K. and Sugimachi, K. (2002) Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits. Circulation 105, 2905-2910
25. Taubman, M. B., Rollins, B. J., Poon, M., Marmur, J., Green, R. S., Berk, B. C. and Nadal-Ginard, B. (1992) JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ. Res. 70, 314-325
26. Guzman, L. A., Whitlow, P. L., Beall, C. J. and Kolattukudy, P. E. (1993) Monocyte chemoattractant protein antibody inhibits restenosis in the rabbit atherosclerotic model. Circulation 88, I-371
27. Egashira, K., Zhao, Q., Kataoka, C., Ohtani, K., Usui, M., Charo, I. F., Nishida, K., Inoue, S., Katoh, M., Ichiki, T. and Takeshita, A. (2002) Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ. Res. 90, 1167-1172
28. Horvath, C., Welt, F. G., Nedelman, M., Rao, P. and Rogers, C. (2002) Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted. Circ. Res. 90, 488-494
29. Kumar, A. G., Ballantyne, C. M., Michael, L. H., Kukielka, G. L., Youker, K. A., Lindsey, M. L., Hawkins, H. K., Birdsall, H. H., MacKay, C. R., LaRosa, G. J. et al. (1997) Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 95, 693-700
30. Birdsall, H. H., Green, D. M., Trial, J., Youker, K. A., Burns, A. R., MacKay, C. R., LaRosa, G. J., Hawkins, H. K., Smith, C. W., Michael, L. H. et al. (1997) Complement C5a, TGF-β1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation 95, 684-692
31. Ono, K., Matsumori, A., Furukawa, Y., Igata, H., Shioi, T., Matsushima, K. and Sasayama, S. (1999) Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Lab. Invest. 79, 195-203
32. Hayashidani, S., Tsutsui, H., Shiomi, T., Ikeuchi, M., Matsusaka, H., Suematsu, N., Wen, J., Egashira, K. and Takeshita, A. (2003) Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 108, 2134-2140
33. Kaikita, K., Hayasaki, T., Okuma, T., Kuziel, W. A., Ogawa, H. and Takeya, M. (2004) Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Am. J. Pathol. 165, 439-447
34. Kolattukudy, P. E., Quach, T., Bergese, S., Breckenridge, S., Hensley, J., Altschuld, R., Gordillo, G., Klenotic, S., Orosz, C. and Parker-Thornburg, J. (1998) Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am. J. Pathol. 152, 101-111
35. Wilson, E. M., Diwan, A., Spinale, F. G. and Mann, D. L. (2004) Duality of innate stress responses in cardiac injury, repair, and remodeling. J. Mol. Cell. Cardiol. 37, 801-811
36. Tarzami, S. T., Cheng, R., Miao, W., Kitsis, R. N. and Berman, J.W. (2002) Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death. J. Mol. Cell. Cardiol. 34, 209-221
37. αi-independent pathway. Biochem. Biophys. Res. Commun. 335, 1008-1016
38. Martire, A., Fernandez, B., Buehler, A., Strohm, C., Schaper, J., Zimmermann, R., Kolattukudy, P. E. and Schaper, W. (2003) Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK/JNK1/2 activation. Cardiovasc. Res. 57, 523-534
39. Morimoto, H., Takahashi, M., Izawa, A., Ise, H., Hongo, M., Kolattukudy, P. E. and Ikeda, U. (2006) Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ. Res. 99, 891-899
40. Dewald, O., Zymek, P., Winkelmann, K., Koerting, A., Ren, G., Abou-Khamis, T., Michael, L. H., Rollins, B. J., Entman, M. L. and Frangogiannis, N. G. (2005) CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ. Res. 96, 881-889
41. Azfer, A., Niu, J., Rogers, L. M., Adamski, F. M. and Kolattukudy, P. E. (2006) Activation of endoplasmic reticulum stress response during the development of ischemic heart disease. Am. J. Physiol. Heart. Circ. Physiol. 291, H1411-H1420
42. Shintani-Ishida, K., Nakajima, M., Uemura, K. and Yoshida, K. (2006) Ischemic preconditioning protects cardiomyocytes against ischemic injury by inducing GRP78. Biochem. Biophys. Res. Commun. 345, 1600-1605
43. Zhang, P. L., Lun, M., Teng, J., Huang, J., Blasick, T. M., Yin, L., Herrera, G. A. and Cheung, J. Y. (2004) Preinduced molecular chaperones in the endoplasmic reticulum protect cardiomyocytes from lethal injury. Ann. Clin. Lab. Sci. 34, 449-457
44. Pan, Y. X., Ren, A. J., Zheng, J., Rong, W. F., Chen, H., Yan, X. H., Wu, C., Yuan, W. J. and Lin, L. (2007) Delayed cytoprotection induced by hypoxic preconditioning in cultured neonatal rat cardiomyocytes: role of GRP78. Life Sci. 81, 1042-1049
45. Cihakova, D and Rose, N. R. (2008) Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 99, 95-114
46. Neu, N., Rose, N. R., Beisel, K.W., Herskowitz, A., Gurri-Glass, G. and Craig, S.W. (1987) Cardiac myosin induces myocarditis in genetically predisposed mice. J. Immunol. 139, 3630-3636
47. Kohyama, K. and Matsumoto, Y. (1999) C-protein in the skeletal muscle induces sever autoimmune polymyositis in Lewis rats. J. Neuroimmunol. 98, 130-135
48. Matsumoto, Y., Tsukada, Y., Miyakoshi, A., Sakuma, H. and Kohyama, K. (2004) C protein-induced myocarditis and subsequent dilated cardiomyopathy: rescue from death and prevention of dilated cardiomyopathy by chemokine receptor DNA therapy. J. Immunol. 173, 3535-3541
49. Kobayashi, Y., Kubo, A., Iwano, M., Sakaguchi, Y., Samejima, K., Kyoda, Y., Yonemasu, K. and Hashimoto, T. (2002) Levels of MCP-1 and GM-CSF mRNA correlated with inflammatory cytokines mRNA levels in experimwntal autoimmune myocarditis in rats. Autoimmunity 35, 97-104
50. Göser, S., Ottl, R., Brodner, A., Dengler, T. J., Torzewski, J., Egashira, K., Rose, N. R., Katus, H. A. and Kaya, Z. (2005) Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1α in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation 112, 3400-3407
51. Shen, Y., Xu, W., Chu, Y. W., Wang, Y., Liu, Q. S. and Xiong, S. D. (2004) Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis. J. Virol. 78, 12548-12556
52. Belperio, J. A. and Ardehali, A. (2008) Chemokines and transplant vasculopathy. Circ. Res. 103, 454-466
53. Yin, R., Zhu, J., Shao, H., Cheng, X., Feng, X., Li, Z. and Jing, H. (2007) Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy. J. Heart Lung Transplant. 26, 485-493
54. Horiguchi, K., Kitagawa-Sakakida, S., Sawa, Y., Li, Z. Z., Fukushima, N., Shirakura, R. and Matsuda, H. (2002) Selective chemokine and receptor gene expressions in allografts that develop transplant vasculopathy. J. Heart Lung Transplant. 21, 1090-1100
55. Russell, M. E., Adams, D. H., Wyner, L. R., Yamashita, Y., Halnon, N. J. and Karnovsky, M. J. (1993) Early and persistent induction of monocyte chemoattractant protein-1 in rat cardiac allografts. Proc. Natl. Acad. Sci. U.S.A. 90, 6086-6090
56. Bharat, A., Kuo, E., Steward, N., Aloush, A., Hachem, R., Trulock, E. P., Patterson, G. A., Meyers, B. F. and Mohanakumar, T. (2008) Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann. Thorac. Surg. 86, 189-195
57. Fleury, S., Li, J., Simeoni, E., Fiorini, E., von Segesser, L. K., Kappenberger, L. and Vassalli, G. (2006) Gene transfer of RANTES and MCP-1 chemokine antagonists prolongs cardiac allograft survival. Gene Ther. 13, 1104-1109
58. Saiura, A., Sata, M., Hiasa, K., Kitamoto, S., Washida, M., Egashira, K., Nagai, R. and Makuuchi, M. (2004) Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy. Arterioscler. Thromb. Vasc. Biol. 24, 1886-1890
59. Haskova, Z., Izawa, A., Contreras, A. G., Flynn, E., Boulday, G. and Briscoe, D. M. (2007) Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection. Transplantation 83, 1595-1601
60. Abdi, R., Means, T. K., Ito, T., Smith, R. N., Najafian, N., Jurewicz, M., Tchipachvili, V., Charo, I., Auchincloss, Jr, H., Sayegh, M. H. and Luster, A. D. (2004) Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo. J. Immunol. 172, 767-775
61. Lee, I., Wang, L., Wells, A. D., Ye, Q., Han, R., Dorf, M. E., Kuziel, W. A., Rollins, B. J., Chen, L. and Hancock, W. W. (2003) Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. J. Immunol. 171, 6929-6935
62. Hognestad, A., Endresen, K., Wergeland, R., Mellembakken, J. R., Mollnes, T. E., Omland, T., Kjekshus, J. K., Aukrust, P. and Andreassen, A. K. (2005) Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis. J. Heart Lung Transplant. 24, 1026-1032
63. de Groot-Kruseman, H. A., Mol, W. M., Niesters, H. G., Maat, A. P., van Gelder, T., Balk, A. H., Weimar, W. and Baan, C. C. (2003) Differential intragraft cytokine messenger RNA profiles during rejection and repair of clinical heart transplants: a longitudinal study. Transplant. Int. 16, 9-14
64. de Groot-Kruseman, H. A., Baan, C. C., Loonen, E. H., Mol, W. M., Niesters, H. G., Maat, A. P., Balk, A. H. and Weimar, W. (2001) Failure to down-regulate intragraft cytokine mRNA expression shortly after clinical heart transplantation is associated with high incidence of acute rejection. J. Heart Lung Transplant. 20, 503-510
65. Belperio, J. A., Keane, M. P., Burdick, M. D., Londhe, V., Xue, Y. Y., Li, K., Phillips, R. J. and Strieter, R. M. (2001) Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J. Clin. Invest. 108, 547-556
66. Fahmy, N. M., Yamani, M. H., Starling, R. C., Ratliff, N. B., Young, J. B., McCarthy, P. M., Feng, J., Novick, A. C. and Fairchild, R. L. (2003) Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants. Transplantation 75, 72-78
67. Mazzone, T., Chait, A. and Plutzky, J. (2008) Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet 371, 1800-1809
68. Van Gaal, L. F., Mertens, I. L. and De Block, C. E. (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444, 875-880
69. Hotamisligil, G. S. (2006) Inflammation and metabolic disorders. Nature 444, 860-867
70. Dandona, P., Aljada, A. and Bandyopadhyay, A. (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 5, 4-7
71. Ohman, M. K., Shen, Y., Obimba, CI., Wright, A. P., Warnock, M., Lawrence, D. A. and Eitzman, D. T. (2007) Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein e-deficient mice. Circulation 6, 798-805
72. Liang, C. P., Han, S., Senokuchi, T. and Tall, A. R. (2007) The macrophage at the crossroads of insulin resistance and atherosclerosis. Circ. Res. 100, 1546-1555
73. Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F. and Spiegelman, B. M. (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271, 665-668
74. Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z. W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J. and Karin, M. (2005) IKK-β links inflammation to obesity-induced insulin resistance. Nat. Med. 11, 191-198
75. Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J. and Shoelson, S. E. (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat. Med. 11, 183-190
76. Sartipy, P. and Loskutoff, D. J. (2003) Monocyte chemoattractant protein-1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. U.S.A. 100, 7265-7270
77. Dragomir, E. and Simionescu, M. (2006) Monocyte chemoattractant protein-1 - a major contributor to the inflammatory process associated with diabetes. Arch. Physiol. Biochem. 112, 239-244
78. Mine, S., Okada, Y., Tanikawa, T., Kawahara, C., Tabata, T. and Tanaka, Y. (2006) Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus. Biochem. Biophys. Res. Commun. 344, 780-785
79. Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K., Kitazawa, R., Kitazawa, S., Miyachi, H., Maeda, S., Egashira, K. and Kasuga, M. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116, 1494-1505
80. Kamei, N., Tobe, K., Suzuki, R., Ohsugi, M., Watanabe, T., Kubota, N., Ohtsuka-Kowatari, N., Kumagai, K., Sakamoto, K., Kobayashi, M. et al. (2006) Overexpression of MCP-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem. 281, 26602-26614
81. Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L. and Ferrante, Jr, A.W. (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116, 115-124
82. Tamura, Y., Sugimoto, M., Murayama, T., Ueda, Y., Kanamori, H., Ono, K., Ariyasu, H., Akamizu, T., Kita, T., Yokode, M. and Arai, H. (2008) Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice. Arterioscler. Thromb. Vasc. Biol. 28, 2195-2201
83. Kirk, E. A., Sagawa, Z. K., McDonald, T. O., O'Brien, K. D. and Heinecke, J. W. (2008) Macrophage chemoattractant protein-1 deficiency fails to restrain macrophage infiltration into adipose tissue. Diabetes 57, 1254-1261
84. Sarafi, M. N., Garcia-Zepeda, E,A., MacLean, J. A., Charo, I. F. and Luster, A. D. (1997) Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J. Exp. Med. 185, 99-109
85. Simeoni, E., Hoffmann, M. M., Winkelmann, B. R., Ruiz, J., Fleury, S., Boehm, B. O., März, W. and Vassalli, G. (2004) Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia 47, 1574-1580
86. Ozcan, U., Cao, Q., Yilmaz, E., Lee, A. H., Iwakoshi, N. N., Ozdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H. and Hotamisligil, G. S. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306, 457-461
87. Ozcan, U., Yilmaz, E., Ozcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z. and Hotamisligil, G. S. (2006) Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137-1140
88. Lincoff, A. M., Wolski, K., Nicholls, S. J. and Nissen, S. E. (2007) Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA, J. Am. Med. Assoc. 298, 1180-1188
89. Pipp, F., Heil, M., Issbrücker, K., Ziegelhoeffer, T., Martin, S., van den Heuvel, J., Weich, H., Fernandez, B., Golomb, G., Carmeliet, P. et al. (2003) VEGFR-1-selective VEGF homologue PIGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ. Res. 92, 378-385
90. Goede, V., Brogelli, L., Ziche, M. and Augustin, H. G. (1999) Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int. J. Cancer 82, 765-770
91. Voskuil, M., van Royen, N., Hoefer, I. E., Seidler, R., Guth, B. D., Bode, C., Schaper, W., Piek, J. J. and Buschmann, I. R. (2003) Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1. Am. J. Physiol. Heart. Circ. Physiol. 284, H1422-H1428
92. Niiyama, H., Kai, H., Yamamoto, T., Shimada, T., Sasaki, K., Murohara, T., Egashira, K. and and Imaizumi, T. (2004) Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization. J. Am. Coll. Cardiol. 44, 661-666
93. Fujiyama, S., Amano, K., Uehira, K., Yoshida, M., Nishiwaki, Y., Nozawa, Y., Jin, D., Takai, S., Miyazaki, M., Egashira, K. et al. (2003) Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ. Res. 93, 980-989
94. Moldovan, N. I., Goldschmidt-Clermont, P. J., Parker-Thornburg, J., Shapiro, S. D. and Kolattukudy, P. E. (2000) Contribution of monocytes/ macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ. Res. 87, 378-384
95. Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K., Oppenheim, J. J. and Murphy, W. J. (2000) Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96, 34-40
96. Hong, K. H., Ryu, J. and Han, K. H. (2005) Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 105, 1405-1407
97. Niu, J., Azfer, A., Zhelyabovska, O., Fatma, S. and Kolattukudy, P. E. (2008) Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP). J. Biol. Chem. 283, 14542-14551
98. Stamatovic, S. M., Keep, R. F., Mostarica-Stojkovic, M. and Andjelkovic, A. V. (2006) CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. J. Immunol. 177, 2651-2661
99. Jiang, Y., Beller, D. I., Frendl, G. and Graves, D. T. (1992) Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J. Immunol. 148, 2423-2428
100. Spinale, F. G. (2007) Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol. Rev. 87, 1285-1342
101. Takemura, G., Ohno, M., Hayakawa, Y., Misao, J., Kanoh, M., Ohno, A., Uno, Y., Minatoguchi, S., Fujiwara, T. and Fujiwara, H. (1998) Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ. Res. 82, 1130-1138
102. Niu, J., Azfer, A., Deucher, M. F., GoldschmidtClermont, P. J. and Kolattukudy, P. E. (2006) Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac- specific expression of MCP-1. J. Mol. Cell. Cardiol. 40, 810-820
103. Niu, J., Azfer, A. and Kolattukudy, P. E. (2006) Monocyte-specific Bcl-2 expression attenuates inflammation and heart failure in monocyte chemoattractant protein-1 (MCP-1)-induced cardiomyopathy. Cardiovasc. Res. 71, 139-148
104. Morimoto, H., Hirose, M., Takahashi, M., Kawaguchi, M., Ise, H., Kolattukudy, P. E., Yamada, M. and Ikeda, U. (2008) MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species. Cardiovasc. Res. 78, 554-562
105. Niu, J., Azfer, A., Rogers, L. M., Wang, X. and Kolattukudy, P. E. (2007) Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc. Res. 73, 549-559
106. Haudek, S. B., Xia, Y., Huebener, P., Lee, J. M., Carlson, S., Crawford, J. R., Pilling, D., Gomer, R. H., Trial, J., Frangogiannis, N. G. and Entman, M. L. (2006) Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc. Natl. Acad. Sci. U.S.A. 103, 18284-18289
107. Frangogiannis, N. G., Dewald, O., Xia, Y., Ren, G., Haudek, S., Leucker, T., Kraemer, D., Taffet, G., Rollins, B. J. and Entman, M. L. (2007) Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 115, 584-592
108. Xia, Y. and Frangogiannis, N. G. (2007) MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy. Inflamm. Allergy Drug Targets 6, 101-107
109. Smith, R. E., Strieter, R. M., Zhang, K., Phan, S. H., Standiford, T. J., Lukacs, N. W. and Kunkel, S. L. (2007) A role for C-C chemokines in fibrotic lung disease. J. Leukocyte Biol. 57, 782-787
110. Moore, B. B., Paine, III, R., Christensen, P. J., Moore, T. A., Sitterding, S., Ngan, R., Wilke, C. A., Kuziel, W. A. and Toews, G. B. (2001) Protection from pulmonary fibrosis in the absence of CCR2 signalling. J. Immunol. 167, 4368-4377
111. Wolf, G., Jocks, T., Zahner, G., Panzer, U. and Stahl, R. A. (2002) Existence of a regulatory loop between MCP-1 and TGF-β in glomerular immune injury. Am. J. Physiol. Renal Physiol. 283, F1075-F1084
112. Gharaee-Kermani, M., Denholm, E. M. and Phan, S. H. (1996) Costimulation of fibroblast collagen and transforming growth factor β1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J. Biol. Chem. 271, 17779-17784
113. Yamamoto, T., Eckes, B., Mauch, C., Hartmann, K. and Krieg, T. (2000) Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 α loop. J. Immunol. 164, 6174-6179
114. Desmouliere, A., Badid, C., Bpchaton-Piallat, M. L and Gabbiani, G. (1997) Apoptosis during wound healing, fibrocontractive disease and vascular wall injury. Int. J. Biochem. Cell. Biol. 29, 19-30
115. Zhou, L., Azfer, A., Niu, J., Graham, S., Choudhury, M., Adamski, F. M., Younce, C., Binkley, P. F. and Kolattukudy, P. E. (2006) Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ. Res. 98, 1177-1185
116. Liang, J., Wang, J., Azfer, A, Song, W., Tromp,G., Kolattukudy, P. E. and Fu, M. (2008) A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. J. Biol. Chem. 283, 6337-6346
117. Bidzhekov, K., Zernecke, A. andWeber, C. (2006) MCP-1 induces a novel transcription factor with proapoptotic activity. Circ. Res. 98, 1107-1109
118. Kim, S. Y., Guijarro, C., O'Donnell, M. P., Kasiske, B. L., Kim, Y. and Keane, W. F. (1995) Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin. Kidney Int. 48, 363-371
119. Bhatia, M., Ramnath, R. D., Chevali, L. and Guglielmotti, A. (2005) Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1259-G1265
120. Kanamori, H., Matsubara, T., Mima, A., Sumi, E., Nagai, K., Takahashi, T., Abe, H., Iehara, N., Fukatsu, A., Okamoto, H. et al. (2007) Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy. Biochem. Biophys. Res. Commun. 360, 772-777